Cardiovascular manifestations of rheumatologic diseasesROMAN, Mary J; SALMON, Jane E.Circulation (New York, N.Y.). 2007, Vol 116, Num 20, pp 2346-2355, issn 0009-7322, 10 p.Article

Surrogate markers for cardiovascular disease : Functional markersCOHN, Jay N; QUYYUMI, Arshed A; HOLLENBERG, Norman K et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 31-46, issn 0009-7322, 16 p., SUPArticle

Surrogate markers for cardiovascular disease : Structural markersMANCINI, G. B; DAHLÖF, Bjorn; DIEZ, Javier et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 22-30, issn 0009-7322, 9 p., SUPArticle

Sexual Activity and Cardiovascular Disease: A Scientific Statement From the American Heart AssociationLEVINE, Glenn N; STEINKE, Elaine E; TESSLER LINDAU, Stacy et al.Circulation (New York, N.Y.). 2012, Vol 125, Num 8, pp 1058-1072, issn 0009-7322, 15 p.Article

Risk factor criteriaSTAMPFER, Meir J; RIDKER, Paul M; DZAU, Victor J et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 3-5, issn 0009-7322, 3 p., SUPArticle

Inflammatory markers and onset of cardiovascular events: Results from the health ABC studyCESARI, Matteo; PENNINX, Brenda W. J. H; PAHOR, Marco et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 19, pp 2317-2322, issn 0009-7322, 6 p.Article

Personalized Cardiovascular Medicine and Drug Development: Time for a New ParadigmLOSCALZO, Joseph.Circulation (New York, N.Y.). 2012, Vol 125, Num 4, pp 638-645, issn 0009-7322, 8 p.Article

MicroRNAs Add a New Dimension to Cardiovascular DiseaseSMALL, Eric M; FROST, Robert J. A; OLSON, Eric N et al.Circulation (New York, N.Y.). 2010, Vol 121, Num 8, pp 1022-1032, issn 0009-7322, 11 p.Article

Baseline ICAM-1 and VCAM-1 Are Increased in Initially Healthy Middle-Aged Men Who Develop Cardiovascular Disease During 6.6 Years of Follow-UpSCHMIDT, Caroline; HULTHE, Johannes; FAGERBERG, Bjorn et al.Angiology. 2009, Vol 60, Num 1, pp 108-114, issn 0003-3197, 7 p.Article

HRT and heart disease: problems and prospectsMAAS, Angela H. E. M; VAN DER GRAAF, Yolanda; VAN DER SCHOUW, Yvonne T et al.Maturitas (Amsterdam). 2004, Vol 47, Num 4, pp 255-258, issn 0378-5122, 4 p.Conference Paper

Air pollution and cardiovascular diseaseFRANCHINI, Massimo; MANNUCCI, Pier Mannuccio.Thrombosis research. 2012, Vol 129, Num 3, pp 230-234, issn 0049-3848, 5 p.Conference Paper

Statin Therapy—Part II: Clinical Considerations for Cardiovascular DiseaseSADOWITZ, Benjamin; SEYMOUR, Keri; COSTANZA, Michael J et al.Vascular and endovascular surgery. 2010, Vol 44, Num 6, pp 421-433, issn 1538-5744, 13 p.Article

LDL-cholestérol et maladies cardiovasculairesBRUCKERT, E.Archives des maladies du coeur et des vaisseaux. Pratique. 2004, Num 134, pp 36-38, issn 1261-694X, 3 p.Article

Statin Therapy—Part I: The Pleiotropic Effects of Statins in Cardiovascular DiseaseSADOWITZ, Benjamin; MAIER, Kristopher G; GAHTAN, Vivian et al.Vascular and endovascular surgery. 2010, Vol 44, Num 4, pp 241-251, issn 1538-5744, 11 p.Article

Physical Activity and Cardiovascular Disease Prevention : Current RecommendationsKOKKINOS, Peter.Angiology. 2008, Vol 59, issn 0003-3197, 28S-29S, SUP2Conference Paper

The Impact of Prevention on Reducing the Burden of Cardiovascular DiseaseKAHN, Richard; ROBERTSON, Rose Marie; SMITH, Robert et al.Circulation (New York, N.Y.). 2008, Vol 118, Num 5, pp 576-585, issn 0009-7322, 10 p.Article

Glucocorticoids and cardiovascular diseaseWALKER, Brian R.European journal of endocrinology. 2007, Vol 157, Num 5, pp 545-559, issn 0804-4643, 15 p.Article

Polyphénols et maladies cardiovasculairesBROUSTET, J.-P.Archives des maladies du coeur et des vaisseaux. Pratique. 2004, Num 134, pp 32-35, issn 1261-694X, 4 p.Conference Paper

Adipocytokines in relation to cardiovascular diseaseVAN DE VOORDE, Johan; PAUWELS, Bart; BOYDENS, Charlotte et al.Metabolism, clinical and experimental. 2013, Vol 62, Num 11, pp 1513-1521, issn 0026-0495, 9 p.Article

Medication Adherence in Cardiovascular DiseaseBAROLETTI, Steven; DELL'ORFANO, Heather.Circulation (New York, N.Y.). 2010, Vol 121, Num 12, pp 1455-1458, issn 0009-7322, 4 p.Article

Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general populationOTERDOOM, Leendert H; GANSEVOORT, Ron T; SCHOUTEN, Jan P et al.Atherosclerosis. 2009, Vol 207, Num 2, pp 534-540, issn 0021-9150, 7 p.Article

Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular diseaseSILVEIRA, Angela; SCANAVINI, Daniela; HAMSTEN, Anders et al.Thrombosis research. 2012, Vol 130, Num 2, pp 221-225, issn 0049-3848, 5 p.Article

Surrogate markers in clinical trials―Challenges and opportunitiesDUIVENVOORDEN, Raphaël; DE GROOT, Eric; STROES, Erik S. G et al.Atherosclerosis. 2009, Vol 206, Num 1, pp 8-16, issn 0021-9150, 9 p.Article

Relationships of inflammatory and haemostatic markers with social class : Results from a population-based study of older menRAMSAY, Sheena; LOWE, Gordon D. O; WHINCUP, Peter H et al.Atherosclerosis. 2008, Vol 197, Num 2, pp 654-661, issn 0021-9150, 8 p.Article

Sexual dimorphism of abdominal aortic aneurysms: A striking example of male disadvantage in cardiovascular diseaseBLOOMER, Lisa D. S; BOWN, Matthew J; TOMASZEWSKI, Maciej et al.Atherosclerosis. 2012, Vol 225, Num 1, pp 22-28, issn 0021-9150, 7 p.Article